ONYIA JUDE (Chief Scientific Officer) sold 29.9% of their position (11K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $1.71M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/29/2026ACC: 0001894425-26-000010
Officer· Chief Scientific Officer
Since Nov 2021
-11K
Net shares
Net seller
$1.71M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
11K acquired · 22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11K
Price / share
$84.74
Trade value
$932.14K
% of position
42.6%
5/27/2026
25.85K→36.85K
Common Stock
Direct
Shares
−11K
Price / share
$155.53
Trade value
$1.71M
% of position
29.9%
5/27/2026
36.85K→25.85K
Total
Net shares
+0.00
Net value
-$778.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2026 | M · Option Exercise | +11K | $84.74 | $932.14K | 42.6% | 25.85K | 36.85K |
| Common Stock Direct | 5/27/2026 | S · Sale | −11K | $155.53 | $1.71M | 29.9% | 36.85K | 25.85K |
| Total | +0.00 | -$778.73K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
11K shares
Shares
−11K
Strike price
84.74
Held after
24.27K
Exercisable
—
5/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock11K shares | 5/27/2026 | M · Option Exercise | −11K | 84.74 | — | 24.27K |